4.3 Article

Screening and validation of a novel T stage-lymph node ratio classification for operable colon cancer

期刊

ANNALS OF TRANSLATIONAL MEDICINE
卷 9, 期 20, 页码 -

出版社

AME PUBLISHING COMPANY
DOI: 10.21037/atm-21-3170

关键词

Colon cancer; lymph node ratio (LNR); tumor; node; metastasis (TNM); survival outcome

资金

  1. China Scholarship Council [201908050148]
  2. National Natural Science Foundation of China [61976249]

向作者/读者索取更多资源

The novel TLNR classification for colon cancer, which combines LNR and T stage, showed better prognostic discrimination, model-fitting ability, and net benefits compared to the AJCC 8th TNM classification in patients with operable stage I-III colon cancer. Further studies are needed to validate the novel TLNR classification.
Background: Lymph node ratio (LNR) has advantages in predicting prognosis compared with American Joint Committee on Cancer (AJCC) pathological N stage. However, the prognostic value of a novel TLNR classification for colon cancer combining LNR and pathological primary tumor stage (T stage) is currently unknown. Methods: We included 62,294 patients with stage I-III colon cancer from the Surveillance, Epidemiology, and End Results Program as a training cohort. External validation was performed in 3,327 additional patients. A novel LNR stage was established and combined with T stage in a novel TLNR classification. Patients with similar survival were grouped according to T and LNR stages, with T1LNR1 as a reference. Results: We developed a novel TLNR classification as follows: stages I (T1LNR1-2, T1LNR4), IIA (T1LNR3, T2LNR1-2, T3LNR1), IIB (T1LNR5, T2LNR3-4, T3LNR2, T4aLNR1), IIC (T2LNR5, T3LNR3-4, T4aLNR2, T4bLNR1), IIIA (T3LNR5, T4aLNR3-4, T4bLNR2), IIIB (T4aLNR5, T4bLNR3-4), and IIIC (T4bLNR5). In the training cohort, the novel TLNR classification had better prognostic discrimination (area under receiver operating characteristic curve, 0.621 vs. 0.608, two-sided P<0.001), superior model-fitting ability for predicting overall survival (Akaike information criteria, 561,129 vs. 562,052), and better net benefits compared with the AJCC 8th tumor/node/metastasis classification. Similar results were found in the validation cohort for predicting both overall and disease-free survival. Conclusions: This novel TLNR classification may provide better prognostic discrimination, model-fitting ability, and net benefits than the AJCC 8th TNM classification, for potentially better stratification of patients with operable stage I-III colon cancer; however, further studies are required to validate the novel TLNR classification.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据